ADC Therapeutics SA - SHS (ADCT)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SHS
Shares, excl. options Q3 2024
54.9M
Holdings value Q3 2024
$173M
Value change Q3 2024
+$3.39M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
76
Number of buys Q3 2024
48
Number of sells Q3 2024
-24
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 54.9M $173M +$3.39M $3.15 78
2024 Q2 51.8M $164M +$51.4M $3.16 73
2024 Q1 34.7M $156M +$7.17M $4.49 37
2023 Q4 34M $56.4M -$3.92M $1.66 35
2023 Q3 39.5M $35.4M -$10.3M $0.90 39
2023 Q2 45.4M $97.5M -$1.94M $2.15 55
2023 Q1 46.6M $90.9M +$6.16M $1.95 57
2022 Q4 38.8M $149M +$3.71M $3.84 59
2022 Q3 36.6M $177M +$9.04M $4.82 60
2022 Q2 34.5M $274M +$4.57M $7.95 53
2022 Q1 34.1M $501M +$2.97M $14.69 46
2021 Q4 33.8M $683M +$19.2M $20.20 51
2021 Q3 32.8M $891M -$45.6M $27.16 53
2021 Q2 33.5M $816M +$17.2M $24.35 56
2021 Q1 32.8M $801M +$19.6M $24.41 56
2020 Q4 32.1M $1.03B +$31.2M $32.01 51
2020 Q3 28.2M $922M +$217M $32.99 52
2020 Q2 21.6M $1B +$1B $46.81 41